PT  - JOURNAL ARTICLE
AU  - Antonelli, Erminia
AU  - Piccolomini, Elena Loli
AU  - Zama, Fabiana
TI  - Switched forced SEIRDV compartmental models to monitor COVID-19 spread and immunization in Italy
AID  - 10.1101/2021.06.21.21259230
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.06.21.21259230
4099  - http://medrxiv.org/content/early/2021/06/25/2021.06.21.21259230.short
4100  - http://medrxiv.org/content/early/2021/06/25/2021.06.21.21259230.full
AB  - This paper presents a new hybrid compartmental model for studying the COVID-19 epidemic evolution in Italy since the beginning of the vaccination campaign started on 2020/12/27 and shows forecasts of the epidemic evolution in Italy. The proposed compartmental model subdivides the population into six compartments and extends the SEIRD model proposed in [E.L.Piccolomini and F.Zama, PLOS ONE, 15(8):1–17, 08 2020] by adding the Vaccinated population and framing the global model as a hybrid-switched dynamical system. Aiming to represent the quantities that characterize the epidemic behaviour from an accurate fit to the observed data, we partition the observation time interval into sub-intervals. The model parameters change according to a switching rule depending on the data behaviour and the infection rate continuity condition. In particular, we study the representation of the infection rate both as linear and exponential piecewise continuous functions. We choose the length of sub-intervals balancing the data fit with the model complexity through the Bayesian Information Criterion. The calibration of the model shows an excellent representation of the epidemic behaviour and thirty days forecasts have proven to reproduce the infection spread reliably. Finally, we discuss different possible forecast scenarios obtained by simulating an increased vaccination rate.Competing Interest StatementThe authors have declared no competing interest.Funding Statementn/aAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:n/aAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are publicly available on the GitHub repository. https://github.com/fzama63/COVID-SEIRDV